Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy.
about
Potential problems and recommendations regarding substitution of generic antiepileptic drugs: a systematic review of literatureUse of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine.The Controversy over Generic Antiepileptic Drugs.Generic products of antiepileptic drugs (AEDs): is it an issue?Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective.Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study.Substitution of anticonvulsant drugs.Requirements for generic anti-epileptic medicines: a regulatory perspective.Switching from brand-name to generic psychotropic medications: a literature review.Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study.Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.Comparison of dissolution profiles and serum concentrations of two lamotrigine tablet formulations.
P2860
Q26749431-C7782375-D3DA-4E66-879A-8505388503B1Q31138033-CC34EDB0-7A56-498F-9C60-478745DBD03EQ34476865-42F7E98B-CEB7-4DE0-9415-B484F0945ABCQ34582885-58505271-2D14-4DFD-B54B-7AC2640E464CQ34667134-64C800EE-0A09-4314-BA37-6FE996EF1F01Q35763872-5674D88A-E4CC-49C9-8BB8-854C0C23F847Q36916999-93FF3F4C-9FF6-4175-8308-BCF7A4F82699Q37240298-328A6D6D-272C-4762-A7EB-E5BA9B05008BQ37428755-305BBFFC-4667-4B8F-B807-29AE905E5C2BQ37813190-23883362-C99F-4B4E-87A1-8C01D8DCF519Q39340691-61E0E7D8-3846-4F6B-95E1-388940FDB1B5Q40706829-BB758CB6-D6B7-4753-B7A4-AA34746E5405Q41963089-7326F719-4DF9-4FF9-8DE5-7E6074F357A6
P2860
Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Identification of adverse reac ...... ine in patients with epilepsy.
@en
Identification of adverse reac ...... ine in patients with epilepsy.
@nl
type
label
Identification of adverse reac ...... ine in patients with epilepsy.
@en
Identification of adverse reac ...... ine in patients with epilepsy.
@nl
prefLabel
Identification of adverse reac ...... ine in patients with epilepsy.
@en
Identification of adverse reac ...... ine in patients with epilepsy.
@nl
P1476
Identification of adverse reac ...... ine in patients with epilepsy.
@en
P2093
John McCormick
Ken G Makus
P304
P356
10.1016/J.CLINTHERA.2007.02.005
P577
2007-02-01T00:00:00Z